Marilena Antoniou

Marilena Antoniou

Auto-generated profile, based on publicly available information

Marilena Antoniou

Institute of Experimental Cardiology, Heidelberg University Hospital, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2023 in Nature Cardiovascular Research
Verified
Journal Article
Open access
PDF file
BBBastian Bruns
Bastian Bruns
MAMarilena Antoniou
Marilena Antoniou
IBIrena Baier
Irena Baier
MJMaximilian Joos
Maximilian Joos
MSMeryem Sevinchan
Meryem Sevinchan
JBJohannes Backs
Johannes Backs
Takotsubo syndrome (TTS) is an acute heart failure syndrome that mimics the symptoms of acute myocardial infarction and is often preceded by emotional and/or physical stress. There is currently no treatment for TTS. Here we show that injection of 2.5 mg kg−1of epinephrine (EPI) into mice recapitulates numerous features of human TTS, including increased myocardial damage and mortality in males. Gene set enrichment analysis of myocardial RNA sequencing after EPI injection revealed significant enrichment of calcineurin-dependent pro-inflammatory gene networks, which was more pronounced in male than in female mice, in agreement with observed sex discrepancies in the mouse phenotype. An increase in calcineurin activity was detected in the circulating cells of patients with TTS, suggesting a systemic nature of the syndrome. Preventive and therapeutic treatment of mice injected with EPI using calcineurin inhibitors cyclosporine and tacrolimus improved heart function and reduced myocardial injury. Our findings suggest that calcineurin inhibition could be a potential therapy for TTS.